Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.755
+0.115 (18.02%)
Nov 5, 2024, 3:49 PM EST - Market open
Athira Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 73.83 | 90.58 | 95.97 | 110.54 | 60.63 | 2.06 | Upgrade
|
| Short-Term Investments | 17.94 | 56.84 | 104.38 | 143.22 | 124.06 | - | Upgrade
|
| Cash & Short-Term Investments | 91.77 | 147.42 | 200.34 | 253.76 | 184.68 | 2.06 | Upgrade
|
| Cash Growth | -50.69% | -26.42% | -21.05% | 37.40% | 8882.59% | -57.32% | Upgrade
|
| Accounts Receivable | - | - | 1.23 | 2.34 | 1.3 | - | Upgrade
|
| Other Receivables | 1.63 | 1.63 | - | - | - | - | Upgrade
|
| Receivables | 1.63 | 1.63 | 1.23 | 2.34 | 1.3 | 0.01 | Upgrade
|
| Prepaid Expenses | 4.93 | 5.68 | 5.96 | 4.7 | 6.36 | 0.1 | Upgrade
|
| Total Current Assets | 106.7 | 154.73 | 207.53 | 260.8 | 192.34 | 2.16 | Upgrade
|
| Property, Plant & Equipment | 3.86 | 4.44 | 5.32 | 5.22 | 3.59 | - | Upgrade
|
| Long-Term Investments | - | - | 44.83 | 65.94 | 83.51 | - | Upgrade
|
| Other Long-Term Assets | 0.69 | 1.08 | 0.48 | 0.06 | 0.13 | - | Upgrade
|
| Total Assets | 111.25 | 160.25 | 258.15 | 332.01 | 279.56 | 2.19 | Upgrade
|
| Accounts Payable | 0.48 | 0.13 | 2.5 | 0.57 | 1.16 | 0.42 | Upgrade
|
| Accrued Expenses | 26.04 | 28.34 | 18.6 | 8.44 | 3.12 | 0.85 | Upgrade
|
| Current Portion of Leases | 0.39 | 0.37 | 0.33 | 0.29 | 0.12 | - | Upgrade
|
| Total Current Liabilities | 26.9 | 28.84 | 21.43 | 9.29 | 4.41 | 1.27 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 1.55 | Upgrade
|
| Long-Term Leases | 1.02 | 1.22 | 1.59 | 1.63 | 0.88 | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | - | 1.04 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 1 | Upgrade
|
| Total Liabilities | 27.92 | 30.06 | 23.02 | 10.92 | 5.28 | 4.86 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 445.77 | 439.74 | 428.62 | 417.36 | 315.29 | 1.36 | Upgrade
|
| Retained Earnings | -362.4 | -309.21 | -191.53 | -95.9 | -41.04 | -21.09 | Upgrade
|
| Comprehensive Income & Other | -0.04 | -0.35 | -1.96 | -0.39 | 0.03 | - | Upgrade
|
| Total Common Equity | 83.34 | 130.19 | 235.14 | 321.08 | 274.28 | -19.72 | Upgrade
|
| Shareholders' Equity | 83.34 | 130.19 | 235.14 | 321.08 | 274.28 | -2.67 | Upgrade
|
| Total Liabilities & Equity | 111.25 | 160.25 | 258.15 | 332.01 | 279.56 | 2.19 | Upgrade
|
| Total Debt | 1.41 | 1.59 | 1.91 | 1.92 | 1 | 1.55 | Upgrade
|
| Net Cash (Debt) | 90.36 | 145.83 | 198.43 | 251.84 | 183.68 | 0.5 | Upgrade
|
| Net Cash Growth | -50.98% | -26.51% | -21.21% | 37.11% | 36417.30% | -87.72% | Upgrade
|
| Net Cash Per Share | 2.36 | 3.84 | 5.26 | 6.82 | 15.35 | 0.14 | Upgrade
|
| Filing Date Shares Outstanding | 38.44 | 38.33 | 37.94 | 37.62 | 37.12 | 3.64 | Upgrade
|
| Total Common Shares Outstanding | 38.44 | 38.17 | 37.88 | 37.38 | 32.49 | 3.64 | Upgrade
|
| Working Capital | 79.8 | 125.89 | 186.1 | 251.51 | 187.93 | 0.89 | Upgrade
|
| Book Value Per Share | 2.17 | 3.41 | 6.21 | 8.59 | 8.44 | -5.42 | Upgrade
|
| Tangible Book Value | 83.34 | 130.19 | 235.14 | 321.08 | 274.28 | -19.72 | Upgrade
|
| Tangible Book Value Per Share | 2.17 | 3.41 | 6.21 | 8.59 | 8.44 | -5.42 | Upgrade
|
| Machinery | 1.42 | 1.4 | 1.13 | 0.59 | 0.08 | - | Upgrade
|
| Construction In Progress | - | - | - | 1.12 | 2.64 | - | Upgrade
|
| Leasehold Improvements | 4.32 | 4.32 | 4.3 | 2.56 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.